| Amy Liana Berke, MD | |
|
1310 S Main St, Ann Arbor, MI 48104-3786 | |
| (734) 929-2696 | |
| Not Available |
| Full Name | Amy Liana Berke |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1310 S Main St, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245598309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301101590 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Ross Summers Md Pllc | 9830099563 | 4 |
News Archive
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients and distal access solutions, today announced the launch of the DAC 070 Catheter.
If you're looking for a simple way to lower your risk of dying from a heart attack, consider going nuts.
IncludeHealth, an internationally recognized provider of inclusive digital health and performance technologies, and Cincinnati Children's Hospital Medical Center, a top-ranked pediatric medical center and research institution, announced today an exclusive licensing agreement to allow IncludeHealth to commercialize a research based digital health technology originally developed at Cincinnati Children's.
Researchers at University of California San Diego School of Medicine, Ludwig Institute for Cancer Research and The Scripps Research Institute, with colleagues in Los Angeles and Japan, report that depriving deadly brain cancer cells of cholesterol, which they import from neighboring healthy cells, specifically kills tumor cells and caused tumor regression and prolonged survival in mouse models.
› Verified 3 days ago
| Entity Name | Ross Summers Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295865954 PECOS PAC ID: 9830099563 Enrollment ID: O20040109000927 |
News Archive
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients and distal access solutions, today announced the launch of the DAC 070 Catheter.
If you're looking for a simple way to lower your risk of dying from a heart attack, consider going nuts.
IncludeHealth, an internationally recognized provider of inclusive digital health and performance technologies, and Cincinnati Children's Hospital Medical Center, a top-ranked pediatric medical center and research institution, announced today an exclusive licensing agreement to allow IncludeHealth to commercialize a research based digital health technology originally developed at Cincinnati Children's.
Researchers at University of California San Diego School of Medicine, Ludwig Institute for Cancer Research and The Scripps Research Institute, with colleagues in Los Angeles and Japan, report that depriving deadly brain cancer cells of cholesterol, which they import from neighboring healthy cells, specifically kills tumor cells and caused tumor regression and prolonged survival in mouse models.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Liana Berke, MD 11992 E Shore Dr, Whitmore Lake, MI 48189-9105 Ph: () - | Amy Liana Berke, MD 1310 S Main St, Ann Arbor, MI 48104-3786 Ph: (734) 929-2696 |
News Archive
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients and distal access solutions, today announced the launch of the DAC 070 Catheter.
If you're looking for a simple way to lower your risk of dying from a heart attack, consider going nuts.
IncludeHealth, an internationally recognized provider of inclusive digital health and performance technologies, and Cincinnati Children's Hospital Medical Center, a top-ranked pediatric medical center and research institution, announced today an exclusive licensing agreement to allow IncludeHealth to commercialize a research based digital health technology originally developed at Cincinnati Children's.
Researchers at University of California San Diego School of Medicine, Ludwig Institute for Cancer Research and The Scripps Research Institute, with colleagues in Los Angeles and Japan, report that depriving deadly brain cancer cells of cholesterol, which they import from neighboring healthy cells, specifically kills tumor cells and caused tumor regression and prolonged survival in mouse models.
› Verified 3 days ago
Ketti Sophia Petersen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. James Robert Neuenschwander, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3131 Professional Dr, Ann Arbor, MI 48104 Phone: 734-995-3200 Fax: 734-995-4254 | |
Ms. Natasha Kristine Nguyen, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1540 E Hospital Dr Spc 5718, Ann Arbor, MI 48109 Phone: 734-936-9777 Fax: 734-936-6897 | |
Ms. Alicia J Cohen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1801 Briarwood Circle, Ann Arbor, MI 48108 Phone: 734-998-7390 | |
Dana Marie O'neill, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Whitehall Dr Ste 130, Ann Arbor, MI 48105 Phone: 734-995-0303 Fax: 734-995-0425 | |
Karl Thomas Rew, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright, Lobby H, Ann Arbor, MI 48105 Phone: 734-647-5640 | |
Dr. Noshir Yazdi Amaria, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 207 Fletcher St, Ann Arbor, MI 48109 Phone: 734-764-8320 |